Immersive nature-based wellbeing program for older adults with cognitive impairment
Official title: Cognitio Avançada: Immersive Nature-Based Wellbeing Program for Older Adults With Cognitive Impairment: A Quasi-Experimental Pre-Post Study
Run by Consorci Sanitari de Terrassa · NCT07802392 · Data updated 2026-11-12
A nature-inspired immersive virtual reality program is being tested to see if it can improve well-being and daily function for older adults with mild to moderate cognitive impairment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 230 (estimated) |
| Sponsor | Consorci Sanitari de Terrassa Academic / other |
| Locations | 1 site (Terrassa, Barcelona) |
| Status | Recruiting |
| Started | March 31, 2026 |
| Main results expected | November 2026 |
| Study ends | December 2026 |
| Registry record updated | September 3, 2026 |
| Trial ID | NCT07802392 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 65 or older with mild to moderate cognitive impairment who can consent (or have a representative) and can attend participating day care centers or residential facilities.
✕Probably not a fit
Individuals with severe cognitive impairment, significant sensory/motor limitations, epilepsy, or conditions contraindicating VR may be unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial tests an immersive virtual reality (VR) program that uses nature environments, mindfulness, cognitive stimulation, and breathing techniques to support cognitive and emotional well-being in older adults. Phase 1 screens safety usability and responses in healthy adults using behavioral and physiological measures. Phase 2 enrolls about 200 participants with mild or moderate cognitive impairment from care facilities to complete 10 VR sessions, with pre- and post-intervention assessments of cognition, mood, daily functioning, and quality of life. The study is conducted across services affiliated with Consorci Sanitari de Terrassa and Suara Serveis SCCL, without a control group in Phase 2.
Why it matters
Potential benefit: If successful, the program could offer a non-pharmacological way to enhance well-being, mood, and daily functioning in older adults with cognitive impairment.
How similar studies have gone: Previous research outdoors or VR-based interventions suggest potential mood and engagement benefits, but results vary and this study adds a focused, nature-based VR approach with an older, cognitively impaired population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 65 years * Diagnosis of mild or moderate cognitive impairment * Ability to understand study procedures and follow instructions * Ability to provide informed consent (or consent provided by a legal representative) * Attendance at participating day care centers or residential facilities (Phase 2) * For Phase 1: healthy adults without cognitive impairment Exclusion Criteria: * Severe cognitive impairment or diagnosis of advanced dementia * Severe visual, auditory, or motor impairments that prevent use of virtual reality * Neurological or psychiatric conditions that may interfere with participation * History of epilepsy or conditions contraindicating virtual reality exposure * Severe behavioral disturbances or agitation * Participation in other clinical studies that may interfere with results
Where it's running
-
Consorci Sanitari de Terrassa
Terrassa, Barcelona, Spain Recruiting
Study contacts
- Study coordinator: Maite Garolera, PhD
- Email: mgarolera@cst.cat
- Phone: +34937310007
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
New flutemetamol F18 formulation to see if it works as well as current for brain amyloid imaging
Researchers are testing a new flutemetamol F18 formulation (GE-287) to see if it identifies brain amyloid as accurately as the current formulation in people 50 and older who are undergoing amyloid PET scans for cognitive decline.
-
Longevity Metrics AI/ML Development Study
Researchers are testing AI models that score health screening tests and predict outcomes like life expectancy for adults, using ongoing follow-up data.
-
Hesperidin for better thinking in overweight older adults
In adults aged 55–75 who are overweight, taking hesperidin or a placebo for 10 weeks will show whether the citrus flavonoid can improve thinking skills like memory, attention, and problem-solving.
-
Structured Receptive Music to Help with Care During Bathing for People with Dementia
A structured daily music program used during hygiene care is being tested to see if it reduces refusals of care by residents with dementia in French nursing homes.
-
Risk of delirium and cognitive problems after TUR-P in older adults
This study tests whether certain perioperative factors can predict delirium and postoperative cognitive dysfunction in people aged 65 and older undergoing transurethral resection.
-
Health Ahead: Comparing AI vs. Humans for Preventive Health Screening
This study tests AI-assisted screening interpretation against human-only reads to see if automated screening can match or improve current practice for adults, especially in underserved areas.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.